Avoid This Big Pharma As New Regulations Churn

AstraZeneca

AstraZeneca (AZN) is a U.K. based, global “full service” pharmaceutical corporation extensively engaged in research & development and marketing of a variety of medications. The current share price is hovering around $46. AstraZeneca markets a broad array of drugs, from neuroscience to infectious diseases. As of today, the company has 79 compounds in differing levels of [...]

Nokia In Denial As Smartphone Kings Pull Ahead

Nokia

Being the CEO of a struggling company is not an enviable job and sadly, this is the position which Nokia’s (NOK) CEO, Stephen Elop, finds himself in presently. When Elop’s predecessor could not stop the decline that was hitting the company hard, Elop took over in 2010 and made certain moves that were geared towards improving the [...]

Baidu: Avoid These High Valuations

Baidu

It is widely known that the giants of the Chinese internet business areBaidu (BIDU), Sina (SINA), Sohu.com (SOHU), Tenecent, and UcWEb. However, Baidu operates the most popular Chinese search engine, dominating the market. It has about 80% market share, having benefited when Google (GOOG) shut down its Chinese search site and redirected visitors to servers in Hong Kong in 2010. On July 11th, [...]

A Hidden Value Play With 50% Upside Potential

Best Buy (BBY)

Best Buy (BBY) has an enormous problem, threatening its very survival. The roots of this problem are deep, and it represents a change beyond the ability of the company’s management to change. Somehow this retailer must find a way to adjust, and quickly. The problem: Moore’s Law. With apologies to the flood of words that have been poured [...]